Transformation of the microvascular system during multistage tumorigenesis

Simian virus SV40 large T Antigen expression in the islets of Langerhans of transgenic mice results in β‐cell hyperproliferation, onset of new blood vessel formation and the development of highly vascularized solid tumors. Angiogenesis in the RIPTag mouse model, as well as in human cancer, is a hallmark of multistage tumorigenesis and precedes the development of solid tumors. In our study, intravital microscopy was used to monitor changes in the blood vessel phenotype, microcirculation and leukocyte adhesion during the progression from normal islets to angiogenic islets and solid tumors. In RIP1‐Tag5 mice, an aberrant microangioarchitecture becomes apparent in early stages during spontaneous tumor development. Notably, the transition from normal to angiogenic islets is characterized by an increase in vessel diameter rather than vessel numbers. Thus, dilatation of existing vessels precedes vessel sprouting. Once initiated, neovascularization in angiogenic islets results in loss of vessel hierarchy and differentiation. Solid insulinomas display a higher vessel density and even more dramatic vessel heterogeneity as revealed by local “hot spots” of neovascularization and irregular vessel diameters. Strikingly, profound changes in the microangioarchitecture are already observed in early angiogenic islets suggesting that key features of the angiogenic vasculature are established prior to the expansion of tumor mass. Moreover, adhesion of leukocytes was found to be dramatically decreased in both angiogenic islets and solid tumors and correlates with morphological alterations of the vasculature. Thus, vessel transformation and reduced leukocyte‐endothelium interactions are not exclusively features of solid tumors but represent early events during tumorigenesis. © 2002 Wiley‐Liss, Inc.

[1]  Shigeyoshi Itohara,et al.  Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis , 2000, Nature Cell Biology.

[2]  J. Werner,et al.  Vascular structure and microcirculation of experimental pancreatic carcinoma in rats. , 2000, The European journal of surgery = Acta chirurgica.

[3]  R K Jain,et al.  Openings between defective endothelial cells explain tumor vessel leakiness. , 2000, The American journal of pathology.

[4]  J. Werner,et al.  Reduced basal and stimulated leukocyte adherence in tumor endothelium of experimental pancreatic cancer , 1999, International journal of pancreatology : official journal of the International Association of Pancreatology.

[5]  D. Granger,et al.  Quantification of murine endothelial cell adhesion molecules in solid tumors. , 1999, American journal of physiology. Heart and circulatory physiology.

[6]  P. Meltzer,et al.  Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. , 1999, The American journal of pathology.

[7]  G. Hämmerling,et al.  Autoaggression and tumor rejection: it takes more than self‐specific T‐cell activation , 1999, Immunological reviews.

[8]  D. Hanahan,et al.  Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. , 1999, Science.

[9]  D. Hanahan,et al.  Tumor microenvironment can restrict the effectiveness of activated antitumor lymphocytes. , 1998, Cancer research.

[10]  N. Weidner,et al.  Tumoural vascularity as a prognostic factor in cancer patients: the evidence continues to grow , 1998, The Journal of pathology.

[11]  Thomas Boehm,et al.  Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance , 1997, Nature.

[12]  Rakesh K. Jain,et al.  Quantitative angiogenesis assays: Progress and problems , 1997, Nature Medicine.

[13]  T Klyscz,et al.  [Cap image--a new kind of computer-assisted video image analysis system for dynamic capillary microscopy]. , 1997, Biomedizinische Technik. Biomedical engineering.

[14]  William Arbuthnot Sir Lane,et al.  Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth , 1997, Cell.

[15]  D. Hanahan,et al.  The rise and fall of apoptosis during multistage tumorigenesis: down-modulation contributes to tumor progression from angiogenic progenitors. , 1996, Genes & development.

[16]  D. Hanahan,et al.  Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.

[17]  G. Groenewegen,et al.  Tumor angiogenesis is accompanied by a decreased inflammatory response of tumor-associated endothelium. , 1996, Blood.

[18]  J. Folkman,et al.  Angiostatin induces and sustains dormancy of human primary tumors in mice , 1996, Nature Medicine.

[19]  G. Groenewegen,et al.  Endothelial intercellular adhesion molecule-1 expression is suppressed in human malignancies: the role of angiogenic factors. , 1996, Cancer research.

[20]  E. Lander,et al.  Tumor suppressor loci on mouse chromosomes 9 and 16 are lost at distinct stages of tumorigenesis in a transgenic model of islet cell carcinoma. , 1995, Cancer research.

[21]  H. Buhr,et al.  Intravenous Contrast Medium Aggravates the Impairment of Pancreatic Microcirculation in Necrotizing Pancreatitis in the Rat , 1995, Annals of surgery.

[22]  Lars Holmgren,et al.  Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma , 1994, Cell.

[23]  M. Dewhirst,et al.  Diminished leukocyte-endothelium interaction in tumor microvessels. , 1992, Cancer research.

[24]  D. Bates,et al.  Intravital video‐capillaroscopy for the study of the microcirculation in psoriasis , 1992, The British journal of dermatology.

[25]  D. Ingber,et al.  Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth , 1990, Nature.

[26]  D. Hanahan,et al.  Induction of angiogenesis during the transition from hyperplasia to neoplasia , 1989, Nature.

[27]  R K Jain,et al.  Mechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: significance of elevated interstitial pressure. , 1988, Cancer research.

[28]  R K Jain,et al.  Determinants of tumor blood flow: a review. , 1988, Cancer research.

[29]  D. Hanahan,et al.  Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. , 1985, Nature.

[30]  L. Orci,et al.  New Perspectives on the Microvasculature of the Islets of Langerhans in the Rat , 1982, Diabetes.

[31]  S. Brem,et al.  Angiogenesis: a marker for neoplastic transformation of mammary papillary hyperplasia. , 1977, Science.

[32]  Dian Feng,et al.  Heterogeneity of the Angiogenic Response Induced in Different Normal Adult Tissues by Vascular Permeability Factor/Vascular Endothelial Growth Factor , 2000, Laboratory Investigation.

[33]  R. Sutherland Tumor hypoxia and gene expression--implications for malignant progression and therapy. , 1998, Acta oncologica.

[34]  N. Bouck,et al.  How tumors become angiogenic. , 1996, Advances in cancer research.

[35]  D. Hanahan,et al.  Modulation of L-selectin ligand expression during an immune response accompanying tumorigenesis in transgenic mice. , 1996, The Journal of clinical investigation.

[36]  R. Jain,et al.  During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium. , 1996, Nature medicine.

[37]  J. Folkman Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.

[38]  C. Streffer,et al.  The vasculature of xenotransplanted human melanomas and sarcomas on nude mice. I. Vascular corrosion casting studies. , 1989, Acta anatomica.